Vaginal Microbiota and Post-cesarean SSI
The Relationship Between Vaginal Microbiota and Post-Cesarean Section Wound Infection
1 other identifier
observational
160
1 country
1
Brief Summary
The goal of this observational study is to investigate the relationship between vaginal microbiota composition and the development of post-cesarean section wound infection in women undergoing cesarean delivery. The main question it aims to answer is: Is there a correlation between specific vaginal microbiota profiles and the incidence of post-cesarean section wound infection? Can specific bacterial taxa or diversity indices within the vaginal microbiota predict the risk of post-cesarean section wound infection? Participants will: Provide vaginal swab samples pre-operatively and post-operatively. Undergo standard post-cesarean section care and follow-up. Have wound assessment performed per standard of care, and have data collected regarding wound infection status. Have demographic and clinical data collected, including but not limited to, antibiotic use, gestational age, and comorbidities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2025
CompletedFirst Posted
Study publicly available on registry
February 21, 2025
CompletedStudy Start
First participant enrolled
June 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 30, 2026
June 15, 2025
June 1, 2025
1 year
February 18, 2025
June 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of Vaginal Microbiota Composition and Surgical Site Infection (SSI) Incidence
This outcome will assess the differences in vaginal microbiota composition between women who develop a surgical site infection (SSI) following cesarean section and those who do not. Microbiota composition will be determined through culture and analysis of vaginal swab samples collected pre-operatively and post-operatively. Comparisons will focus on identifying significant variations in bacterial taxa, diversity indices, and overall microbial community structure between the two groups.
4 weeks after the surgery.
Secondary Outcomes (1)
Predictive Value of Specific Vaginal Bacterial Species for Surgical Site Infection (SSI).
6 months
Study Arms (1)
cesarean section group
This observational study will enroll 160 women undergoing cesarean section. Participants will provide vaginal swab samples for culture, both pre-operatively and post-operatively. They will be monitored post-operatively for the development of wound infections, with wound assessments performed according to standard clinical practice. Demographic and clinical data, including antibiotic use, gestational age, and comorbidities, will be collected to assess the relationship between vaginal microbiota and post-cesarean wound infections.
Interventions
Participants will undergo vaginal swab collection both pre-operatively, immediately prior to the cesarean section, and post-operatively, within a defined timeframe after the procedure. The swabs will be collected using sterile swabs, following standardized procedures to ensure accurate sampling of the vaginal microbiota. The collected samples will then be sent to a designated laboratory for culture and analysis. This process will identify and characterize the bacterial composition of the vaginal microbiota, allowing researchers to investigate potential correlations between specific microbial profiles and the development of post-cesarean section wound infections
Eligibility Criteria
This study will enroll pregnant women undergoing either elective or emergency cesarean section at or beyond 37 weeks of gestation. Participants must have a singleton pregnancy. Women with known immunodeficiency, chronic infections, or those who have received antibiotics within two weeks prior to delivery will be excluded. Additionally, women with ruptured membranes for more than 18 hours will be excluded to minimize the potential influence of prolonged exposure to mixed flora. The study aims to investigate the relationship between vaginal microbiota and post-cesarean section wound infection within this defined population.
You may qualify if:
- Pregnant women undergoing elective or emergency cesarean section (CS).
- Singleton pregnancy.
- Cesarean section performed at ≥ 37 weeks of gestation.
You may not qualify if:
- Use of antibiotics within two weeks prior to delivery.
- Known immunodeficiency.
- Chronic infections.
- Ruptured membranes for more than 18 hours.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Al-Hussein University Hospital
Cairo, 11633, Egypt
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Muhamed Alhagrasy
Al-Azhar University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer and consultant at Obstetrics and Gynecology Department.
Study Record Dates
First Submitted
February 18, 2025
First Posted
February 21, 2025
Study Start
June 30, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
July 30, 2026
Last Updated
June 15, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- 5 years after publication.
- Access Criteria
- Access to de-identified Individual Participant Data (IPD) will be granted to qualified researchers with a demonstrated scientific need and a clearly defined research question. Researchers must submit a formal request to MuhamedAhmed.216@azhar.edu.eg, outlining their research proposal, including the specific data requested, the intended use of the data, and their qualifications. Requests will be reviewed by the Department of Obstetrics and Gynecology, Al-Azhar University to ensure scientific merit and ethical compliance. Researchers must agree to sign a data sharing agreement that outlines the terms of data use, including restrictions on redistribution and requirements for appropriate data security and confidentiality.
De-identified Individual Participant Data (IPD) that underlie the results reported in this article, including study protocol, statistical analysis plan, and analytic code, will be made available upon reasonable request to qualified researchers after publication. Requests should be submitted to MuhamedAhmed.216@azhar.edu.eg. Proposals will be reviewed by the Department of Obstetrics and Gynecology, Al-Azhar University to ensure that the proposed use of the data is scientifically sound and ethical. Data will be shared in a secure, password-protected format, and a data sharing agreement will be required to ensure responsible use and protection of participant confidentiality. The data will be available for 5 years following publication. Publication of results will be made without identifiers